Efficacy and Safety of CTL019 in the First US Phase II Multicenter Trial in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of an Interim Analysis
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, University of Southern California, Children's Hospital of Los Angeles, University of Utah, Cincinnati Children's Hospital Medical Center, University of Minnesota, Children's Mercy Hospital, Oregon Health & Science University, Duke University, Duke Medical Center, University of Michigan, University of Wisconsin–Madison, Novartis (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2592081641